for serotyping rotaviruses recovered from 134 Venezuelan infants over a period of 15 months. One hundred and nine of the specimens were typed with the following distribution: serotype 1, 48%; serotype 2, 16%; serotype 3, 22%; and serotype 4, 14%. Three specimens reacted with two different monoclonal antibodies. In addition, 6 specimens (5%) containing enough outer capsid antigen could not be typed; partial RNA sequence analysis of the glycoprotein gene from three of these six strains failed to reveal sequence differences with prototype strains that could be serotyped with the monoclonal antibodies. Variations in the recovery rates of the different serotypes were observed. Serotypes 2, 3, and 4 predominated at the beginning of the study, and serotype 1 predominated at the end of the study. Diarrheal illness appeared to be more prolonged in infants shedding rotavirus serotypes 1 and 3 than in those shedding serotypes 2 and 4.
The development of a rotavirus vaccine should decrease the high diarrheal mortality rates observed in infants and young children in developing countries (14) . A Jennerian approach to vaccine development by using heterologous bovine (23) or simian (7) strains to immunize the human host has been tested with some success. However, it appears from recent vaccine failures (3, 15 ) that more successful vaccines will require the introduction of strains antigenically similar to those rotaviruses commonly isolated from infants with disease. Both the planning and the evaluation of second-generation rotavirus vaccine candidates require the availability of a simple serotyping test that can be used in the field. In addition, widespread use of such a test will greatly enhance knowledge of the natural history and epidemiology of rotaviruses. The use of enzyme immunoassays based on the specific recognition of serotype-specific epitopes on VP7 (the major rotavirus neutralizing antigen) has been reported by several groups (2, 11, 20, 21) . A serotyping test recently developed by Taniguchi et al. (21) , which uses anti-VP7 neutralizing monoclonal antibodies against the four epidemiologically important human serotypes (i.e., serotypes 1, 2, 3, and 4), was used in this study to analyze the relative frequency and temporal distribution of those serotypes among infants hospitalized with acute diarrhea at a pediatric hospital in Caracas, Venezuela.
MATERIALS AND METHODS
Rotavirus detection. Stool specimens from 134 infants (8 days to 24 months of age) known to be positive for rotavirus were studied. The children were admitted for acute diarrhea to the emergency ward at the Hospital de Ninos J. M. De Los Rios in Caracas, Venezuela, between December 1981 and February 1983. Rotavirus detection was performed by a confirmatory enzyme-linked immunosorbent assay (ELISA) as previously described (16) . Most of the specimens had been previously subgrouped by ELISA (24) , and some of * Corresponding author. them were subjected to RNA extraction for electrophoretic and cross-hybridization analyses (7) .
Monoclonal antibodies. Four serotype-specific monoclonal antibodies that recognize VP7 were used: KU-4 (serotype 1), S2-2G10 (serotype 2), YO-lE2 (serotype 3), and ST-2G7 (serotype 4). In addition, monoclonal antibody YO-2C2, which recognizes the VP3 outer capsid protein of all four serotypes in ELISAs, was used as a positive control to determine the presence of double-shelled virus particles. A monoclonal antibody (YO-156) that recognizes an inner capsid common epitope in all group A rotaviruses was used as a control to detect the presence of rotavirus antigen in the sample (22) . The reactivity of these monoclonal antibodies with a series of laboratory strains has been previously described (21, 22) . Rotavirus serotyping. ELISA serotyping was performed as previously described (21) . Briefly, the wells of polyvinyl microtiter plates were coated with a 1:10,000 dilution of monoclonal antibody (ascitic fluid) in phosphate-buffered saline (PBS). After overnight incubation at 4°C, the plates were washed twice with PBST (PBS containing 0.05% Tween 20 and 0.02% sodium azide). Bovine serum albumin (1%) was added to the wells, and the plates were again incubated overnight at 4°C. After the plates were washed twice with PBST, 50 ,ul of sample (5 to 10% stool suspensions in PBS or tissue culture fluid) was placed in each well. After overnight incubation, the plates were washed three times with PBST (19) . Stool suspensions were preincubated for 1 h at 37°C with trypsin (10 ,ug/ml) and adsorbed onto cells in roller tubes. After 1 h, the inocula were washed and the cells were fed with minimal essential medium with Eagle salts containing antibiotics, glutamine, and trypsin (0.5 ,ug/ml). The tubes were rotated at 37°C for 7 to 10 days or until cytopathic effect was apparent. Positive control rotavirus strains Wa (serotype 1), DS-1 (serotype 2), P (serotype 3), and ST 3 (serotype 4) were grown in stationary cultures of MA-104 cells and included in every assay.
RNA sequencing. In some instances, when the monoclonal antibodies failed to detect the serotype specificity of certain isolates, the viruses were amplified in tissue culture, partially purified, and subjected to in vitro transcription (6) to generate single-stranded RNAs. Two selected areas of the RNA species encoding VP7 in those isolates were sequenced. RNA was sequenced by the primer extension method by using two synthetic oligonucleotides targeted to nucleotides 532 to 552 and 801 to 819 of the VP7 gene as previously described (10) .
RESULTS
Relative recovery rates of rotavirus serotypes 1, 2, 3, and 4. A total of 134 rotavirus-positive specimens were examined by the monoclonal antibody assay. As judged by the reactivity of the specimens in the wells precoated with crossreactive monoclonal antibody directed to VP3, 118 specimens contained a sufficient number of double-capsid particles to enable serotyping. The remaining specimens reacted positively (albeit some of them reacted weakly) in the VP6 monoclonal antibody-coated wells but did not react in wells coated with VP3 cross-reactive monoclonal antibody. Table 1 (10) . NT, Nontypable; *, previously published sequences (10) . days) than in those infected with serotypes 2 or 4 (P < 0.01 in each case).
Six of the specimens which could not be typed had sufficient double-shelled virus particles to react with the common VP3 antibody. To further investigate these strains, we attempted tissue culture isolation, amplification, and sequencing of regions of the VP7 protein gene involved in neutralization specificity. Only three of the six strains grew in tissue culture. RNA sequences corresponding to two hyperdivergent regions (amino acids 87 to 101 and 208 to 221) are shown in Fig. 1 Four human rotavirus serotypes have been described in studies from different regions of the world (9, 25) . In addition, two new serotypes have been proposed but their epidemiological importance is not known (1, 17 2. It is also of interest that a strong correlation was observed between strains serotyped here and their previously reported hybridization patterns with the laboratory prototype strains Wa and DS-1 (7). Thus, while rotavirus serotype 2 presented a high degree of sequence similarity with the DS-1 prototype strain, rotavirus serotypes 1, 3, and 4 hybridized strongly with the Wa virus prototype. These correlations further support our previous observations on the existence of two rotavirus families (5, 7) .
No differences were observed in the mean age at which the different serotypes were detected. However, significant differences were observed in the duration of illness. Thus, serotype 1 and 3 strains appear to induce a more prolonged illness than serotypes 2 and 4. It is difficult to assess whether such differences are related to virulence properties among the strains, the presence of preexisting antibodies in the infants, or some other factor.
Universality (10, lOa) . It is possible that the three nontypable strains represent different monotypes or antigenic variants or that their corresponding VP7 epitopes react with the serotyping monoclonal antibodies below the detectable threshold levels of this assay. Recent studies of neutralization escape mutants derived with monoclonal antibody KU-4 (the serotype 1 monoclonal antibody used in this study) indicate that this antibody maps to amino acid 213 (K. Taniguchi, personal observation), which is similar in the three nontypable strains to the corresponding amino acid of other serotype 1 viruses. No amino acid substitutions were detected between strains HN226 and HN384 and the serotype 1 strain D. Amino acid substitutions observed at positions 94, 97, 208, and 218 in one of the strains (HN254) matched the sequence of M37, a serotype 1 laboratory strain which does react with monoclonal antibody KU4. Therefore alternative explanations must be sought to explain the lack of reactivity of the three nontypable strains with the serotype 1-specific monoclonal antibody. Among them, the possibility that changes in a different area of VP7 (which appears to be a highly conformation-dependent antigen) or changes in VP3 (by steric hindrance) may be responsible for the observed phenomena is being explored.
